Results 71 to 80 of about 1,949,032 (203)
Risk stratification for hepatitis B virus related hepatocellular carcinoma
Hepatitis B virus (HBV) infection is the major cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) worldwide, especially in the Asia-Pacific region.
Lin, Chih-Lin;Kao, Jia-Horng, 高嘉宏
core
Recent studies have demonstrated that the effect of inhibition of HBV replication can be achieved by RNA interference (RNAi) at both the cellular and organismal levels. However, HBV replication cannot be completely inhibited by this method. To completely
Tang, Kai-Fu +12 more
core
Plots of Log10 IU/ml HBV-DNA/HBsAg ratio by levels of HBV replication.
Plots of Log10 IU/ml HBV-DNA/HBsAg ratio by levels of HBV replication.
Edouard Tuaillon (81329) +9 more
core +1 more source
Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver [PDF]
The largest single underlying cause of hepatocellular carcinoma (HCC) worldwide is hepatitis B virus (HBV) infection. Hepatitis B virus increases cellular oxidative stress and the development of HCC occurs after a long latency period.
J A Ross +11 more
core +1 more source
Occult HBV infection among Egyptian hepatocellular carcinoma patients
Background Occult HBV infection accelerates the progression of liver fibrosis, cirrhosis, and finally leading to hepatocellular carcinoma (HCC). This study analyzed the occult HBV-genotypes in HCC patients. Methods To achieve our objective, matched serum
Mansor Tarek M +3 more
doaj +1 more source
Seroepidemiology of hepatitis B virus in Addis Ababa Ethiopia: transmission patterns and vaccine control [PDF]
A community-based seroepidemiological survey of Addis Ababa, Ethiopia was conducted in 1994 to inform on the transmission dynamics and control of hepatitis B virus (HBV) infection.
Cutts, FT +11 more
core +1 more source
With an estimated 350–400 million people worldwide chronically infected with hepatitis B virus (HBV), and the subsequent serious complications caused by liver damage including cirrhosis, liver failure, and hepatocellular carcinoma, HBV infection remains ...
Jeng-Fu Yang +11 more
doaj +1 more source
Summary. We evaluated tolerability and virological and clinical impact of anti-Hepatitis B Virus (HBV) nucleos(t)ide analogues in cirrhotic patients with HBV/Hepatitis C Virus (HCV) coinfection. The virological and clinical course of 24 consecutive HBsAg/
Stanzione M. +10 more
core +1 more source
To define HBsAg-mutations correlated with different serum HBV-DNA levels in HBV chronically-infected drug-naive ...
Cortese, M +73 more
core +1 more source
Jin Yu,1 Yuan Zhu,1 Shiyi Zhao,1 Xiaogang Li2 1School of Medicine, Wuhan University of Science and Technology, Wuhan, 430065, People’s Republic of China; 2Department of Biliary and Pancreatic Surgery, Xiangyang Central Hospital, Affiliated Hospital of ...
Yu J, Zhu Y, Zhao S, Li X
doaj

